Darunavir - CAS 206361-99-1 (free); 635728-49-3 (Ethanolate)

Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents. Developed by pharmaceutical company Tibotec, darunavir is named after Arun K. Ghosh, the chemist who discovered the molecule at the University of Illinois at Chicago. It was approved by the Food and Drug Administration (FDA) on June 23, 2006. .

Catalog Number: I005974

CAS Number: 206361-99-1 (free); 635728-49-3 (Ethanolate)

Molecular Formula: C27H37N3O7S

Molecular Weight:547.66

Purity: ≥95%

* For research use only. Not for human or veterinary use.


SynonymsTMC114; TMC 114; TMC-114; Darunavir; brand name Prezista.;(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate


Molecular Formula: C27H37N3O7S
Molecular Weight547.66
Target:protease inhibitor
SolubilitySoluble in DMSO.
Storage0 - 4°C for short term ,or -20 °C for long term